Product Recalls in Arizona

Product recalls affecting Arizona — including food, drugs, consumer products, medical devices, and vehicles distributed to Arizona. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,759 recalls have been distributed to Arizona in the last 12 months.

52,339 total recalls
2,759 in last 12 months

Showing 78817900 of 13,449 recalls

DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 2 mcg/mL+Bupivacaine 0.0625% PF in 0.9% Sodium Chloride 250 mL...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL (as citrate) 5 mcg/mL In 250 mL 0.9% Sodium Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 2 mcg/mL + Ropivacaine 0.2% PF in NS 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: BUPIVacaine HCl 0.125% In 250 mL 0.9% Sodium Chloride Bag Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL (as citrate) 10 mcg per mL in 0.9% Sodium Chloride 250 mL Bag...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL (as citrate) 10 mcg per mL in 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine HCl 60 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: ceFAZolin 3 g added to 100 mL 0.9% Sodium Chloride Recalled by SCA...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 2 mcg/mL + BUPIvacaine 0.125% PF in 0.9% Sodium Chloride 250 mL...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: PHENYLephrine 40 mg in 0.9% Sodium Chloride 250 mL Recalled by SCA...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: NORepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mL Recalled by...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: fentaNYL 10 mcg/mL PF in Sodium Chloride 250 mL (Total Dose=2500 mcg)...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: Potassium Chloride 40 meq Added to Sodium Chloride 0.9% 250 mL Recalled by...

The Issue: Lack of Assurance of Sterility; product has the potential to leak.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 14, 2017· SCA Pharmaceuticals

Recalled Item: Diltiazem 125 mg in 0.9% Sodium Chloride Recalled by SCA Pharmaceuticals Due...

The Issue: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Chlorhexidine Gluconate Oral Rinse Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q2 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Akorn Inc

Recalled Item: Halyard 24-Hour Oral Care Kit q4 Recalled by Akorn Inc Due to...

The Issue: Crystallization with subpotent out of specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 12, 2017· Pfizer Inc.

Recalled Item: Deferoxamine Mesylate for injection Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm failed to control impurity for color change at the API...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 11, 2017· Dr. Reddy's Laboratories, Inc.

Recalled Item: Pravastatin Sodium Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: high out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund